The tariff classification of Memantine Hydrochloride Tablets in dosage form, from India
Issued November 4, 2022 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9240
Headings: 3004
Product description
Memantine Hydrochloride, imported in 5 mg and 10 mg tablets, is an orally active NMDA receptor antagonist. It is indicated for the treatment of moderate to severe dementia of the Alzheimer's type.
CBP rationale
The applicable subheading for the Memantine Hydrochloride Tablets in dosage form will be 3004.90.9240, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Other.
Full text
N328751 November 4, 2022 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3004.90.9240 Mrs. Rhona M. Keeler NorthStar Healthcare 3300 Cork Airport Business Park Kinsale Road, Cork T12 XN72 Ireland RE: The tariff classification of Memantine Hydrochloride Tablets in dosage form, from India Dear Mrs. Keeler: In your letter dated October 14, 2022, you requested a tariff classification ruling. Memantine Hydrochloride, imported in 5 mg and 10 mg tablets, is an orally active NMDA receptor antagonist. It is indicated for the treatment of moderate to severe dementia of the Alzheimer's type. The applicable subheading for the Memantine Hydrochloride Tablets in dosage form will be 3004.90.9240, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Elinzanetant (CAS No. 929046-33-3) in bulk form and LYNKUET® (E linzanetant) Capsules in dosage form, from Germany
The tariff classification of Carbidopa and Levodopa Extended-Release Capsules in dosage form, from India
The tariff classification of Cyclobenzaprine Hydrochloride Tablets in dosage form, from India
The tariff classification off Edaravone Injection in dosage form, from India
The tariff classification of Balsalazide Disodium Capsules USP and Carbidopa Tablets in dosage form, from Taiwan and India, respectively
The tariff classification of PREVDUO (neostigmine methylsulfate and glycopyrrolate) injection in dosage form, from India
The tariff classification of Baclofen Oral Suspension in dosage form, from Canada
The tariff classification of Carbidopa/Levodopa Tablets, Dexamethasone Tablets and Leuprolide Acetate Injection in dosage form, from India
The tariff classification of Tizanidine Hydrochloride Tablets in dosage form, from India
The tariff classification of Dimethyl Fumarate Delayed Release Capsules and Meclizine Hydrochloride Tablets in dosage form, from India
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →